Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Little Green Pharma Ltd. ( (AU:LGP) ) has shared an update.
Little Green Pharma Ltd is hosting an investor webinar to present its FY2025 financial results, including profitability, adjusted EBITDA, revenue, and recent financing outcomes. The webinar, led by Managing Director Paul Long, will offer a Q&A session and aims to provide insights into the company’s financial performance and strategic positioning in the medicinal cannabis industry.
The most recent analyst rating on (AU:LGP) stock is a Buy with a A$0.21 price target. To see the full list of analyst forecasts on Little Green Pharma Ltd. stock, see the AU:LGP Stock Forecast page.
More about Little Green Pharma Ltd.
Little Green Pharma Ltd (ASX:LGP) is a leading global medicinal cannabis company with vertically integrated operations across Europe and Australia. The company offers a diverse portfolio of cannabis-based medicines distributed across Australia and over 12 export markets. It operates three production facilities in Denmark and Australia, positioning itself as a key player in global medicinal cannabis markets. LGP generates revenue through the sale of medicinal cannabis products and its domestic Health House distribution business, providing investors with exposure to global medicinal cannabis demand and scalable growth opportunities.
Average Trading Volume: 85,214
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$33.44M
Learn more about LGP stock on TipRanks’ Stock Analysis page.